Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-05 11:30:53 - browse：41929

Adobe

The Food and Drug Administration has cleared Otsuka Pharmaceutical’s digital treatment for major depressive disorder, offering a new option for millions of people who struggle with the stubborn mental health condition.

Called Rejoyn, the smartphone-based treatment for major depressive disorder symptoms was developed with digital health company Click Therapeutics, and it is intended for use by prescription alongside antidepressants. The six-week program delivers a novel “cognitive-emotional training” technique, in which people are asked to identify and recall faces showing different emotions. Researchers hypothesize that the technique targets the brain’s dorsolateral prefrontal cortex and the amygdala and may “enhance cognitive control over emotional information processing.” Patients also receive cognitive behavioral therapy.

Rejoyn has been in development since 2018, and Otsuka is the first drug company to receive FDA clearance for a digital treatment for a mental health condition. But that landmark comes amid many questions about whether such digital therapeutics deliver their advertised results — and whether they can gain traction with clinicians, insurers, and patients. Prescription digital therapeutics have yet to see a blockbuster success, and several companies have gone out of business trying to create one.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： BD to buy Edwards patient monitoring unit for $4.2 billion

WSS

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Data integrity in scientific journals requires "effort" by publishers, institutions

Eli Lilly’s Zepbound improved liver scarring in mid

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

knowledge

Wikipedia

Wikipedia

Drug repurposing or repositioning? The language matters

Structure Therapeutics oral GLP

Guidelines to prevent youth baseball injuries need more muscle

An outdated Medicare rule harms dementia patients with anxiety

Supreme Court strikes down use of affirmative action

Illumina board agrees to spin off Grail, as divestment plans proceed

What does generative AI mean for health care? We asked experts

Sutter Health’s antitrust win overturned by appeals court

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

How CO2 helps viruses stay alive longer in the air

explore

It's time to retire 'poor historian' from clinicians' vocabularies

Wearables generate powerful data but its not useful to doctors, yet

Arc Institute generative AI designs new CRISPR systems

Fight over Supreme Court dialysis ruling puts kidney patients at risk

Stopping antidepressants leads to symptoms for 1 in 6 patients

Second House panel advances two

focus

knowledge

explore

focus